Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Acorda Therapeutics announces successful QT study of Fampridine-SR

Jan. 30, 2008

FDA approves Emend for Injection as part of treatment for CINV

Jan. 30, 2008

Acrux reports results for phase I fentanyl trial using metered-dose transdermal spray

Jan. 30, 2008

Medivation plans pivotal confirmatory phase III Dimebon trial in AD

Jan. 30, 2008

FDA accepts sNDA for Fentora for management of breakthrough pain

Jan. 30, 2008

Nabilone improves pain, quality of life in fibromyalgia patients

Jan. 30, 2008

Asenapine demonstrates long-term efficacy in bipolar disorder

Jan. 30, 2008

Recent patents disclose novel neuropsychiatric agents

Jan. 30, 2008

Successful gene transfer via lumbar puncture alleviates chronic pain in rats

Jan. 29, 2008

Quantum Genomics and INSERM to codevelop QGC-002 for stroke and cardiac ischemia

Jan. 29, 2008

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...